Avacopan Notches a Win in ANCA-Associated Vasculitis Avacopan Notches a Win in ANCA-Associated Vasculitis

Avacopan was found to be efficacious and safe for treating antineutrophil cytoplasmic antibody – associated vasculitis in the phase 3   ADVOCATE trial.Medscape Medical News

Source: Medscape Medical News Headlines - June 8, 2020 Category: Consumer Health News Tags: Rheumatology News Source Type: news